131 related articles for article (PubMed ID: 8905399)
21. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.
Molano I; Alonso MG; Mirón C; Redondo E; Requena JM; Soto M; Nieto CG; Alonso C
Vet Immunol Immunopathol; 2003 Mar; 92(1-2):1-13. PubMed ID: 12628759
[TBL] [Abstract][Full Text] [Related]
22. Cloning and characterization of the Leishmania (Viannia) braziliensis Hsp70 gene. Diagnostic use of the C-terminal fragment rLb70(513-663).
Zurita AI; Rodríguez J; Piñero JE; Pacheco R; Carmelo E; del Castllo A; Valladares B
J Parasitol; 2003 Apr; 89(2):372-8. PubMed ID: 12760657
[TBL] [Abstract][Full Text] [Related]
23. Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population.
Nakhaee A; Taheri T; Taghikhani M; Mohebali M; Salmanian AH; Fasel N; Rafati S
Vet Parasitol; 2004 Jan; 119(2-3):107-23. PubMed ID: 14746971
[TBL] [Abstract][Full Text] [Related]
24. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
25. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
[TBL] [Abstract][Full Text] [Related]
26. B-cell epitopes of antigenic proteins in Leishmania infantum: an in silico analysis.
Assis LM; Sousa JR; Pinto NF; Silva AA; Vaz AF; Andrade PP; Carvalho EM; De Melo MA
Parasite Immunol; 2014 Jul; 36(7):313-23. PubMed ID: 24606067
[TBL] [Abstract][Full Text] [Related]
27. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis.
Talmi-Frank D; Strauss-Ayali D; Jaffe CL; Baneth G
Clin Vaccine Immunol; 2006 Feb; 13(2):271-6. PubMed ID: 16467337
[TBL] [Abstract][Full Text] [Related]
28. Mapping of a visceral leishmaniasis-specific immunodominant B-cell epitope of Leishmania donovani Hsp70.
Wallace GR; Ball AE; MacFarlane J; el Safi SH; Miles MA; Kelly JM
Infect Immun; 1992 Jul; 60(7):2688-93. PubMed ID: 1377180
[TBL] [Abstract][Full Text] [Related]
29. Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins.
Vale DL; Lage DP; Machado AS; Freitas CS; de Oliveira D; Galvani NC; Fernandes BB; Luiz GP; Oliveira JS; Oliveira-da-Silva JA; Ramos FF; Santos TTO; Siqueira WF; Alves LA; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Bueno LL; Fujiwara RT; Machado-de-Ávila RA; Martins VT; Coelho EAF
Vet Parasitol; 2021 Aug; 296():109513. PubMed ID: 34225189
[TBL] [Abstract][Full Text] [Related]
30. Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis.
Rafati S; Nakhaee A; Taheri T; Ghashghaii A; Salmanian AH; Jimenez M; Mohebali M; Masina S; Fasel N
Exp Parasitol; 2003; 103(3-4):143-51. PubMed ID: 12880591
[TBL] [Abstract][Full Text] [Related]
31. Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes.
Toledo-Machado CM; Bueno LL; Menezes-Souza D; Machado-de-Avila RA; Nguyen C; Granier C; Bartholomeu DC; Chávez-Olórtegui C; Fujiwara RT
Parasit Vectors; 2015 Feb; 8():133. PubMed ID: 25889286
[TBL] [Abstract][Full Text] [Related]
32. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of a monoclonal antibody recognising specifically the HSP70 from Leishmania.
Pérez-Alvarez MJ; Larreta R; Alonso C; Requena JM
Parasitol Res; 2001 Nov; 87(11):907-10. PubMed ID: 11728013
[TBL] [Abstract][Full Text] [Related]
34. Epitope mapping of recombinant Leishmania donovani virulence factor A2 (recLdVFA2) and canine leishmaniasis diagnosis using a derived synthetic bi-epitope.
Mendes TM; Roma EH; Costal-Oliveira F; Dhom-Lemos LC; Toledo-Machado CM; Bruna-Romero O; Bartholomeu DC; Fujiwara RT; Chávez-Olórtegui C
PLoS Negl Trop Dis; 2017 May; 11(5):e0005562. PubMed ID: 28557986
[TBL] [Abstract][Full Text] [Related]
35. Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera.
Thomas MC; Longobardo MV; Carmelo E; Marañón C; Planelles L; Patarroyo ME; Alonso C; López MC
Clin Exp Immunol; 2001 Mar; 123(3):465-71. PubMed ID: 11298135
[TBL] [Abstract][Full Text] [Related]
36. Canine visceral leishmaniasis: a comparative study of real-time PCR, conventional PCR, and direct agglutination on sera for the detection of Leishmania infantum infection.
Mohammadiha A; Haghighi A; Mohebali M; Mahdian R; Abadi AR; Zarei Z; Yeganeh F; Kazemi B; Taghipour N; Akhoundi B; Barati M; Mahmoudi MR
Vet Parasitol; 2013 Feb; 192(1-3):83-90. PubMed ID: 23153824
[TBL] [Abstract][Full Text] [Related]
37. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
[TBL] [Abstract][Full Text] [Related]
38. Recombinant Leishmania (Leishmania) infantum Ecto-Nucleoside Triphosphate Diphosphohydrolase NTPDase-2 as a new antigen in canine visceral leishmaniasis diagnosis.
de Souza RF; Dos Santos YL; de Souza Vasconcellos R; Borges-Pereira L; Caldas IS; de Almeida MR; Bahia MT; Fietto JL
Acta Trop; 2013 Jan; 125(1):60-6. PubMed ID: 23022017
[TBL] [Abstract][Full Text] [Related]
39. Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein.
Dias DS; Ribeiro PAF; Salles BCS; Santos TTO; Ramos FF; Lage DP; Costa LE; Portela ASB; Carvalho GB; Chávez-Fumagalli MA; Caligiorne RB; Oliveira JS; Magalhães-Soares DF; Silva ES; Galdino AS; Menezes-Souza D; Duarte MC; Gonçalves DU; Coelho EAF
Parasitol Int; 2018 Jun; 67(3):344-350. PubMed ID: 29408435
[TBL] [Abstract][Full Text] [Related]
40. Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.
Oliveira GG; Magalhães FB; Teixeira MC; Pereira AM; Pinheiro CG; Santos LR; Nascimento MB; Bedor CN; Albuquerque AL; dos-Santos WL; Gomes YM; Moreira ED; Brito ME; Pontes de Carvalho LC; de Melo Neto OP
Am J Trop Med Hyg; 2011 Dec; 85(6):1025-34. PubMed ID: 22144438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
